By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BaroFold, Inc. 

Corporate Office
1 Mapleton Avenue
Boulder  Colorado  80304  U.S.A.
Phone: 303-926-0337 Fax: 303-926-4292



Company News
BaroFold, Inc. Awarded Patent For Using High Pressure To Improve The Safety Profile Of Biologic Drugs 4/23/2014 9:48:27 AM
BaroFold, Inc. and Lonza Inc. Announce a Technology Evaluation Agreement for PreEMT™, a High Pressure Protein Refolding Technology 1/16/2013 9:12:19 AM
BaroFold, Inc. and Boehringer Ingelheim Corporation Announce Strategic Agreement on PreEMT™ High Pressure Protein Refolding Technology 11/13/2012 8:14:09 AM
BaroFold, Inc. Grants Exclusive License for Interferon Beta Products Developed Using PreEMT(TM) Technology to Nuron Biotech 5/17/2010 9:21:03 AM
BaroFold, Inc. Appoints J. William Freytag, Ph.D. as President and Chief Executive Officer 1/28/2009 6:18:12 AM
BaroFold, Inc. Initiates First Human Studies for Multiple Sclerosis Drug Candidate, BaroFeron™ 6/16/2008 1:15:49 PM
Jon S. Saxe Appointed to Board of Directors of BaroFold, Inc. 4/16/2008 8:38:29 AM
BaroFold, Inc. and Avecia Announce Development and Manufacturing Agreement 10/9/2007 8:25:36 AM
BaroFold, Inc. (Jobs) to Raise $12 Million in Private Placement 5/24/2007 9:28:08 AM
BaroFold, Inc. to Present at C21 BioVentures Conference 5/18/2007 12:02:43 PM